Drug Safety Quarterly is provided as a service to members from the ACR Drug Safety Committee, and is committed to providing news, insight and critical review of safety issues germane to anti-rheumatic therapy.
The information and views contained herein represent those of the DSQ authors/editors, and do not represent guidelines, official positions or statements from the ACR. The ACR is an independent professional medical and scientific society that does not guarantee, warrant or endorse any commercial product or service.
Send questions, comments or suggestions to DSQ@rheumatology.org.
